Citadel Advisors »

Cognition Therapeutics shares owned by Citadel Advisors

Quarter-by-quarter ownership of Cognition Therapeutics (CGTX) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Cognition Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cognition Therapeutics held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cognition Therapeutics by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2026-03-31 $20k 26k 0.76
2025-12-31 $218k 161k 1.35
2024-06-30 $45k 27k 1.66
2022-03-31 $28k 11k 2.67

More positions owned by Citadel Advisors

State Str Spdr S&p 500 Etf T Tr Unit Call Option (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
NVIDIA Corporation Call Option (NVDA)
Tesla Motors Call Option (TSLA)
Spdr Gold Tr Gold Shs Call Option (GLD)
Apple Call Option (AAPL)
Meta Platforms Cl A Call Option (META)
Microsoft Corporation Call Option (MSFT)
Amazon Call Option (AMZN)
Micron Technology Call Option (MU)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Netflix Call Option (NFLX)
Broadcom Call Option (AVGO)
Alphabet Cap Stk Cl C Call Option (GOOG)

View all positions for Citadel Advisors

Top funds holding Cognition Therapeutics

BIOS Capital Management
Vanguard Group
Vanguard Capital Management
Davenport & Co
Chescapmanager
Renaissance Technologies
BlackRock
Geode Capital Management
Hilton Capital Management
Dauntless Investment Group
Vanguard Fiduciary Trust
CM Management
Jane Street
Sigma Planning
State Street Corporation

View all funds holding Cognition Therapeutics